Arezoo Salami Khaneshan

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Coronavirus Disease

Ejection Fraction

Top Venues

Immunity, inflammation and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Pershang Nazemi, SeyedAhmad SeyedAlinaghi, Ayein Azarnoush, Avin Mabadi, Arezoo Salami Khaneshan, Mohammad Reza Salehi
Serum C-reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID-19: A systematic review. Immunity, inflammation and disease 11 (12) (2024)
Kiavash Semnani, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, SeyedAhmad SeyedAlinaghi, Shirin Esmaeili, Farzin Halabchi, Zahra Alizadeh, Amir Salami, Arezoo Salami Khaneshan
Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study. Immunity, inflammation and disease 12 (5) (2024)
Kiavash Semnani, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, SeyedAhmad SeyedAlinaghi, Shirin Esmaeili, Farzin Halabchi, Zahra Alizadeh, Amir Salami, Arezoo Salami Khaneshan
Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study. Immunity, inflammation and disease 12 (5) (2024)
Pershang Nazemi, SeyedAhmad SeyedAlinaghi, Ayein Azarnoush, Avin Mabadi, Arezoo Salami Khaneshan, Mohammad Reza Salehi
Serum C-reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID-19: A systematic review. Immunity, inflammation and disease 11 (12) (2024)
Kiavash Semnani, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, SeyedAhmad SeyedAlinaghi, Shirin Esmaeili, Farzin Halabchi, Zahra Alizadeh, Amir Salami, Arezoo Salami Khaneshan
Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study. Immunity, inflammation and disease 12 (5) (2024)